SpanishOSPRO: Transcultural Adaptation and Validation to Spanish of the OSPRO Questionnaires

Sponsor
University of Valencia (Other)
Overall Status
Recruiting
CT.gov ID
NCT05869695
Collaborator
University of Alcala (Other), Escoles Universitaries Gimbernat (Other), Hospital ASEPEYO Sant Cugat (Other), Consorci Sanitari de Terrassa (Other)
200
2
43
100
2.3

Study Details

Study Description

Brief Summary

Clinical guidelines for managing musculoskeletal pain recommend first, assessing and identifying any signs of severe physical conditions (i.e."red flags") and then, asessing the psychosocial prognostic factors of poor outcomes (i.e."yellow flags"). The Optimal Sreening for Prediction of Referral and Outcome (OSPRO) cohort studies were designed to develop and validate standard assessment tools for Review Of Systems (OSPRO-ROS) and Yellow Flags (OSPRO-YF).

Condition or Disease Intervention/Treatment Phase
  • Other: OSPRO-ROS Questionnaire
  • Other: OSPRO-YF Questionnaire

Detailed Description

The objectives of this study were to translate and cross-cultural adapt OSPRO-ROS and OSPRO-YF questionnaires to Spanish and to investigate their psychometric properties for their use in subjects with musculoskeletal pain.To accomplish the objectives proposed, this study was developed in two phases:Phase I: Cross-cultural adaptation process.Phase II: Psychometric properties evaluation.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Transcultural Adaptation and Validation to Spanish of the Optimal Screening for Prediction of Referral and Outcome (OSPRO) Questionnaires for Review-Of-Systems (OSPRO-ROS) and Yellow-Flags (OSPRO-YF) in Subjects With Musculoskeletal Pain.
Actual Study Start Date :
Nov 30, 2020
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
OSPRO-ROS: 100 patients presenting musculoskeletal pain

Patients between 18 and 75 years of age with primary complaints involving the cervical spine, lumbar spine, shoulder or knee. Were able to read and comprehend Spanish.

Other: OSPRO-ROS Questionnaire
Completion of questionnaires
Other Names:
  • Result of complementary tests
  • OSPRO-ROS retest
  • OSPRO-YF: 100 patients presenting musculoskeletal pain

    Patients between 18 and 75 years of age with primary complaints involving the cervical spine, lumbar spine, shoulder or knee. Were able to read and comprehend Spanish.

    Other: OSPRO-YF Questionnaire
    Completion of questionnaires
    Other Names:
  • Chronic Pain Acceptance Questionnaire (CPAQ)
  • Fear-Avoidance Beliefs Questionnaire (FABQ)
  • Pain Catastrophizing Scale (PCS)
  • Patient Health Questionnaire-9 (PHQ-9)
  • State Trait Anxiety Inventory (STAI)
  • Tampa Scale for Kinesiophobia-11 (TSK-11)
  • OSPRO-YF retest
  • Outcome Measures

    Primary Outcome Measures

    1. Patient-Reported Outcome Measure (PROM) development: Translation and Cross Cultural Adaptation to the Spanish population of the Optimal Screening for Prediction of Referral and Outcome (OSPRO) questionnaires. [from September 2018 to July 2021]

      Two native Spanish speakers, health experienced in musculoskeletal pain and knowledge of English, translated into Spanish the Optimal Screening for Prediction of Referral and Outcome-Review of Systems (OSPRO-ROS) questionnaire original (English) and the Optimal Screening for Prediction of Referral and Outcome Yellow-Flags (OSPRO-YF) original questionnaire (English). Two native English speakers, knowledge of Spanish, reverse-translate the text to Spanish. 25 participants with musculoskeletal pain completed the Optimal Screening for Prediction of Referral and Outcome (OSPRO) questionnaires. This outcome will be evaluated according the Consensus-based Standards for the selections of health Measurement Instruments (COSMIN) Risk of Bias checklist for PROMs, using their scoring manual: very good/adequate/doubtful/inadequate/NA for each standar.

    Secondary Outcome Measures

    1. OSPRO questionnaires Psychometric property Validation [from January to June 2024]

      The validity and reliability of the Spanish version translated from the questionnaires Optimal Screening for Prediction of Referral and Outcome (OSPRO) will be assessed. This outcome will be evaluated according the Consensus-based Standards for the selections of health Measurement Instruments (COSMIN) Risk of Bias checklist for PROMs, using their scoring manual: very good/adequate/doubtful/inadequate/NA for each standar.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    OSPRO-ROS:
    1. Were coming to the emergency department on their first visit.

    2. With acute musculoskeletal pain.

    3. Were able to read and comprehed Spanish language.

    OSPRO-YF:
    1. Were seeking outpatient physical therapy treatment.

    2. With chronic musculoskeletal pain involving the cervical spine, lumbar spine, shoulder or knee.

    3. Were able to read and comprehend Spanish language.

    Exclusion Criteria:
    1. Widespread chronic pain syndrome (e.g. fibromyalgia or irritable bowel syndrome).

    2. Neuropathic pain syndrome (e.g. complex regional pain syndrome or diabetic neuropathy).

    3. Psychiatric history (currently in care of mental health care provider or taking > 2 precription psychiatric medications)

    4. Cancer (currently receiving treatment for active cancer)

    5. Neurological disorder (e.g. stroke, spinal cord injury, or traumatic brain injury).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Asepeyo Sant Cugat Sant Cugat Del Vallès Barcelona Spain 08174
    2 Consorci Sanitari de Terrassa Terrassa Barcelona Spain 08227

    Sponsors and Collaborators

    • University of Valencia
    • University of Alcala
    • Escoles Universitaries Gimbernat
    • Hospital ASEPEYO Sant Cugat
    • Consorci Sanitari de Terrassa

    Investigators

    • Principal Investigator: ENRIQUE LLUCH GIRBÉS, UNIVERSITAT DE VALÈNCIA

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Enrique Lluch Girbés, Associate Professor, University of Valencia
    ClinicalTrials.gov Identifier:
    NCT05869695
    Other Study ID Numbers:
    • 102999
    First Posted:
    May 22, 2023
    Last Update Posted:
    May 22, 2023
    Last Verified:
    May 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Enrique Lluch Girbés, Associate Professor, University of Valencia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 22, 2023